Two school districts in Florida have reached a settlement with Juul, after accusing the company of selling e-cigarettes to minors.
On Wednesday, members of the Palm Beach County School Board in Florida approved a preliminary settlement agreement with an e-cigarette manufacturer. This came as a result of joining a nationwide lawsuit brought forward by over 1,400 government agencies.
According to a report by The Palm Beach Post, officials in the area have stated that this settlement agreement could result in over $10 million in compensation to schools in Palm Beach County over the next five years.
The school district, government agencies, and 32 tribal governments have filed a joint lawsuit against the company, along with 8,500 individuals.
According to the Orlando Sentinel, as part of a settlement agreement with an e-cigarette company, public schools in Orange County, including Orlando, will receive approximately $5.4 million. The company was accused of marketing its products to minors.
In June 2020, the Orlando County Public Schools joined thousands of other districts and individuals in suing Juul.
Last December, the company reached a settlement agreement worth hundreds of millions of dollars regarding the design, manufacture, production, advertising, marketing, distribution, sales, use, and performance of Juul products.
Reference sources:
Two school districts in Florida have reached a settlement with e-cigarette company Juul Labs.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
